[Animal Research, Research services, Research models, DIO]
The expanding reach of GLP-1 research and the role of the diet-induced obesity (DIO) model
Glucagon-like peptide-1 (GLP-1) agonists, such as semaglutide and liraglutide, are major anti-obesity and anti-diabetes therapeutics that have produced clinically meaningful metabolic benefits. While...
